相关实验视频
Updated: May 26, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
慢性病和未来心力衰竭中的高血压
1Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Current opinion in cardiology
|February 25, 2025
概括
新的治疗方法,如SGLT-2抑制剂和非类固醇矿物质皮质体受体对抗剂 (nsMRA),可显著降低高血压和慢性病 (CKD) 患者心力衰竭的风险. 这些治疗也减缓了CKD的进展,影响了当前的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 高血压和慢性病 (CKD) 是心力衰竭的重要危险因素.
- 最近的进展为管理这些相互关联的疾病提供了新的治疗途径.
研究的目的:
- 审查关于SGLT-2抑制剂,非类固醇矿物质皮质体受体对抗剂 (nsMRA) 和GLP-1受体对抗剂的最新发现.
- 为了评估它们在预防高血压和CKD患者心力衰竭方面的有效性.
主要方法:
- 审查最近的大型临床试验.
- 分析了糖尿病和非糖尿病病,高血压和心力衰竭患者的数据.
主要成果:
- SGLT-2 抑制剂和nsMRA显著减少心力衰竭事件和住院治疗.
- 这些疗法还可以减缓CKD的进展.
- 在患有和没有病的患者中观察到的益处.
结论:
- 现在,SGLT-2抑制剂是糖尿病,CKD和心力衰竭患者的推第一线治疗方法.
- nsMRA的使用正在增长,在心力衰竭和早期CKD中可能取代螺旋.
- 这些发现正在重塑高血压和CKD的管理.
相关概念视频
Heart Failure Drugs: Diuretics
332
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
332
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
370
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
370
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Antihypertensive Drugs: Potassium-Sparing Diuretics
436
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
436

